Claes Glassell

Born: 1951

Nationality: Swedish citizen

Independence: Independent of the Company and management and of major shareholders.

Direct or related person ownership: 10,000 class B shares.

Committee work: Member of the People & Renumeration Committee.

Other current significant assignments: Board Director of Cambrec Corp. Senior advisor to Permira.

Claes Glassell was elected a Director of the Kinnevik Board in 2024. He was COO and President of Cambrex Corp. (1999-2003), CEO of Cerus Corp. (2004-2011), and CEO of CMC Biologics (2011-2015). He also chaired LSNE (2017-2021) and Quotient Sciences (2019-2022) and has held senior roles and board positions in public and private companies, including Vitrolife AB, Cellartis AB, and Nobel Chemicals. Claes has also been involved with the Swedish Chamber of Commerce in New York and the Swedish Chemical Industry Association. He holds a master’s degree in chemical engineering from Chalmers University of Technology.